$NWBO's spun clinical trial data has many flaws that FDA is not likely to buy. A recent post on Seeking Alpha provides a good description of the deficiencies in their "new" trial design: https://seekingalpha.com/news/3836107-nwbo-st...0a%20panel.
(0)
(0)
Northwest Biotherapeutics Inc. (NWBO) Stock Research Links